Definition:
This market covers ophthalmologicals and otologicals, i.e., drugs for the sensory organs eye and ear, respectively. Ophthalmologicals are used to treat diseases of the eye such as wet age-related macular degeneration, geographic atrophy, and glaucoma. Typical dosage forms are eye drops or injections into the eye (intravitreal) and, in the case of otologicals, through the eardrum into the middle ear.
Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Company examples: Regeneron Pharmaceuticals, Novartis, Bayer, Alcon, AbbVie
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Jun 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The Sensory Organ Drugs market in Zimbabwe has been experiencing significant growth in recent years.
Customer preferences: Zimbabwe has a high prevalence of eye and ear diseases, which has led to an increased demand for sensory organ drugs. The majority of the population residing in rural areas, where access to healthcare is limited, has resulted in a higher demand for over-the-counter sensory organ drugs.
Trends in the market: There has been a surge in the demand for sensory organ drugs in Zimbabwe due to the increased prevalence of eye and ear diseases. The market has seen a shift towards generic drugs due to their affordability compared to branded drugs. The government has also been promoting the use of locally manufactured drugs, which has led to an increase in domestic production.
Local special circumstances: The Zimbabwean healthcare system has been struggling due to economic and political instability. The government has been unable to provide adequate healthcare facilities and services, leading to a higher demand for over-the-counter drugs. Additionally, the lack of awareness and education regarding eye and ear diseases has resulted in many people self-medicating, leading to an increased demand for over-the-counter sensory organ drugs.
Underlying macroeconomic factors: Zimbabwe has been facing an economic crisis, with high inflation rates and a shortage of foreign currency. This has resulted in the devaluation of the Zimbabwean dollar and a rise in the cost of imported drugs. The government has been promoting local manufacturing to reduce the reliance on imports and improve the economy. The pharmaceutical industry has been identified as a key sector for economic growth, leading to an increase in investment in the sector.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights